Uroporphyria in Hfe mutant mice given 5-aminolevulinate: A new model of Fe-mediated porphyria cutanea tarda
Peter R. Sinclair1,2,3, Nadia Gorman1,2, Heidi S. Walton1,2, William J. Bement1, Jacqueline F. Sinclair1,2,3, Glenn S. Gerhard1,4, Juliana G. Szakacs5, Nancy C. Andrews6,7,8, Joanne E. Levy6,9,10
1VA Medical Center, White River Junction, VT
2Departments of Biochemistry, Dartmouth Medical School, Hanover, NH
3Pharmacology/Toxicology, Dartmouth Medical School, Hanover, NH
4Pathology, Dartmouth Medical School, Hanover, NH
5VA Medical Center, Salt Lake City, UT
6Division of Hematology/Oncology, Children's Hospital, Boston, MA
7Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA
8Departments of Pediatrics, Harvard Medical School, Brigham and Women's Hospital, Boston, MA
9Departments of Medicine, Brigham and Women's Hospital, Boston, MA
10Hematology Division, Brigham and Women's Hospital, Boston, MA;